These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8709641)

  • 21. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro long-term culture of human primitive hematopoietic cells supported by murine stromal cell line MS-5.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Yoneya T; Kakeda M; Tsumura H; Ohashi H; Mori KJ
    Leukemia; 1997 Apr; 11 Suppl 3():468-73. PubMed ID: 9209428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
    Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
    Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The murine stromal cell line AFT024 acts specifically on human CD34+CD38- progenitors to maintain primitive function and immunophenotype in vitro.
    Thiemann FT; Moore KA; Smogorzewska EM; Lemischka IR; Crooks GM
    Exp Hematol; 1998 Jul; 26(7):612-9. PubMed ID: 9657136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative assay that evaluates the capacity of human stromal cells to support granulomonopoiesis in situ.
    Tamayo E; Charbord P; Li J; Hervé P
    Stem Cells; 1994 May; 12(3):304-15. PubMed ID: 7521240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flt3 ligand enhances the yield of primitive cells after Ex vivo cultivation of CD34+ CD38dim cells and CD34+ CD38dim CD33dim HLA-DR+ cells.
    Dooley DC; Xiao M; Oppenlander BK; Plunkett JM; Lyman SD
    Blood; 1997 Nov; 90(10):3903-13. PubMed ID: 9354657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.
    Srour EF; Brandt JE; Briddell RA; Leemhuis T; van Besien K; Hoffman R
    Blood Cells; 1991; 17(2):287-95. PubMed ID: 1717081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells.
    Croisille L; Auffray I; Katz A; Izac B; Vainchenker W; Coulombel L
    Blood; 1994 Dec; 84(12):4116-24. PubMed ID: 7527666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A functional comparison of CD34 + CD38- cells in cord blood and bone marrow.
    Hao QL; Shah AJ; Thiemann FT; Smogorzewska EM; Crooks GM
    Blood; 1995 Nov; 86(10):3745-53. PubMed ID: 7579341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
    Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
    Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
    Muench MO; Cupp J; Polakoff J; Roncarolo MG
    Blood; 1994 Jun; 83(11):3170-81. PubMed ID: 7514903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM; Shields LE; Andrews RG
    Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
    Tsujino Y; Wada H; Misawa M; Kai S; Hara H
    Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.